SEC Form 4 · accession 0001225208-26-006362
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Monson
Officer — EVP and CFO
Period of report
Jul 1, 2026
Accepted (ET)
Jul 2, 2026 · 4:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2026 | M | 2,087 | $0.00 | A | 40,073 | D | |
| Common Stock | Jul 1, 2026 | F | 1,010 | $43.06 | D | 39,063 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jul 1, 2026 | M | 2,087 | D | — | Jul 1, 2029 | Common Stock | 2,087 | 6,263 | D |
Explanation of responses
- F1Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.